Company Filing History:
Years Active: 2003-2007
Title: The Innovative Mind of Steven Pirie-Shepherd
Introduction
Steven Pirie-Shepherd, an accomplished inventor based in Waltham, MA, has made significant contributions to the field of biomedical innovation. With a total of two patents to his name, he has focused his work on understanding and harnessing the complexities of angiogenesis and associated diseases, including cancer.
Latest Patents
Steven Pirie-Shepherd's recent patents showcase his innovative approach to tackling critical health issues. His first patent, titled "Deglycosylated kringle 1-3 region fragments of plasminogen and methods of use," discloses compositions that contain deglycosylated fragments of the kringle 1-3 region of plasminogen. These compositions exhibit increased antiangiogenic activity, providing promising methods for treating various angiogenesis-associated diseases such as cancer.
The second patent, "Compositions and methods for inhibiting angiogenesis," details methods that reduce or inhibit angiogenesis, tumor growth, and endothelial cell proliferation through the administration of specific compositions. It includes pharmaceutical formulations that incorporate fragments or derivatives of antithrombin III, aiming to identify novel inhibitors that can effectively alter angiogenesis in mammals, targeting disorders that stem from these processes.
Career Highlights
Pirie-Shepherd's career is marked by his association with reputable institutions such as the Children's Hospital and Children's Medical Center Corporation. His work at these organizations has enabled him to engage in advanced research aimed at developing therapeutic solutions to some of the most pressing medical challenges.
Collaborations
Throughout his career, Steven Pirie-Shepherd has collaborated with notable figures in the field, including M Judah Folkman and Michael S O'Reilly. These partnerships have likely enriched his research insights and strengthened the impact of his inventions in the medical community.
Conclusion
Steven Pirie-Shepherd's contributions to the fields of angiogenesis and cancer treatment through his innovative patents reflect a commitment to advancing healthcare technologies. His ongoing research and collaborations continue to pave the way for new therapeutic approaches, influencing both the scientific community and patient outcomes.